Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C44H56N8O7.C2H4O2 |
Molecular Weight | 869.0168 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(O)=O.CC(C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC2=CNC3=CC=CC=C23)NC(=O)[C@H](CC4=CC=C(O)C=C4)NC(=O)[C@H](C)N(C)C(=O)[C@H](CC5=CC=CC=C5)NC1=O
InChI
InChIKey=FIKSSPSBVSPVFU-WIKDFEFZSA-N
InChI=1S/C44H56N8O7.C2H4O2/c1-26(2)38-43(58)50-37(23-28-12-6-5-7-13-28)44(59)52(4)27(3)39(54)48-35(22-29-17-19-31(53)20-18-29)41(56)49-36(24-30-25-46-33-15-9-8-14-32(30)33)42(57)47-34(40(55)51-38)16-10-11-21-45;1-2(3)4/h5-9,12-15,17-20,25-27,34-38,46,53H,10-11,16,21-24,45H2,1-4H3,(H,47,57)(H,48,54)(H,49,56)(H,50,58)(H,51,55);1H3,(H,3,4)/t27-,34-,35-,36+,37-,38-;/m0./s1
Seglitide (previously known as L363,586 or MK-678), a cyclic, hexapeptide analog of somatostatin-14, is a somatostatin receptor 2 (SSTR2) agonist. This compound was studied in Alzheimer's disease. Besides, it possessed inhibitory actions on rat growth hormone (GH) release and thus could have a role in the treatment of acromegaly. Intravenous and intranasal administration of seglitide to diabetic subjects was effective in reducing both fasting and postprandial hyperglycemia. Thus, this compound could be useful in the control of unstable diabetes. In addition, preclinical studies have shown that seglitide had potential as a treatment for diabetic retinopathy and macular degeneration. However, the further studied of this compound were discontinued.
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C62799
Created by
admin on Sat Dec 16 07:48:53 GMT 2023 , Edited by admin on Sat Dec 16 07:48:53 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL311695
Created by
admin on Sat Dec 16 07:48:53 GMT 2023 , Edited by admin on Sat Dec 16 07:48:53 GMT 2023
|
PRIMARY | |||
|
URM20C99DG
Created by
admin on Sat Dec 16 07:48:53 GMT 2023 , Edited by admin on Sat Dec 16 07:48:53 GMT 2023
|
PRIMARY | |||
|
9854212
Created by
admin on Sat Dec 16 07:48:53 GMT 2023 , Edited by admin on Sat Dec 16 07:48:53 GMT 2023
|
PRIMARY | |||
|
DTXSID80244001
Created by
admin on Sat Dec 16 07:48:53 GMT 2023 , Edited by admin on Sat Dec 16 07:48:53 GMT 2023
|
PRIMARY | |||
|
X-96
Created by
admin on Sat Dec 16 07:48:53 GMT 2023 , Edited by admin on Sat Dec 16 07:48:53 GMT 2023
|
PRIMARY | |||
|
C152318
Created by
admin on Sat Dec 16 07:48:53 GMT 2023 , Edited by admin on Sat Dec 16 07:48:53 GMT 2023
|
PRIMARY | |||
|
99248-33-6
Created by
admin on Sat Dec 16 07:48:53 GMT 2023 , Edited by admin on Sat Dec 16 07:48:53 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD